Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Sep-24 8:00 PM View:  | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 07-Sep-24 | Payment of Exercise | 1,065 | $0.39 | $415.35 | (< 1%) 168.44K to 167.38K | |
| 09-Sep-24 8:00 PM View: | Wettig Thane CEO Director | Fibrogen Inc (FGEN) | 06-Sep-24 | Payment of Exercise | 2,363 | $0.39 | $921.57 | (< 1%) 425.68K to 423.32K | |
| 09-Sep-24 8:00 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 06-Sep-24 | Payment of Exercise | 17,395 | $0.39 | $6,784.05 | (5%) 321.74K to 304.34K | |
| 09-Sep-24 8:00 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 06-Sep-24 | Payment of Exercise | 16,050 | $0.39 | $6,259.50 | (9%) 184.49K to 168.44K | |
| 05-Aug-24 4:18 PM View: | Wettig Thane CEO Director | Fibrogen Inc (FGEN) | 01-Aug-24 | Payment of Exercise | 20,840 | $0.47 | $9,794.80 | (5%) 446.52K to 425.68K | |
| 25-Jun-24 4:30 PM View: | Wettig Thane CEO Director | Fibrogen Inc (FGEN) | 22-Jun-24 | Payment of Exercise | 782 | $1.13 | $883.66 | (< 1%) 447.3K to 446.52K | |
| 13-Jun-24 4:30 PM View: | Adib Deyaa Chief Medical Officer | Fibrogen Inc (FGEN) | 12-Jun-24 | Private Purchase | 22,123 | $1.17 | $25,883.90 | 37% 60.0K to 82.12K | |
| 10-Jun-24 6:37 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 07-Jun-24 | Payment of Exercise | 1,182 | $1.10 | $1,300.20 | (< 1%) 185.67K to 184.49K | |
| 10-Jun-24 6:37 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 06-Jun-24 | Payment of Exercise | 17,797 | $1.19 | $21,178.40 | (9%) 203.47K to 185.67K | |
| 07-Jun-24 7:00 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 06-Jun-24 | Payment of Exercise | 19,289 | $1.19 | $22,953.90 | (6%) 341.03K to 321.74K | |
| 07-Jun-24 7:00 PM View: | Wettig Thane CEO Director | Fibrogen Inc (FGEN) | 06-Jun-24 | Payment of Exercise | 2,255 | $1.19 | $2,683.45 | (< 1%) 449.56K to 447.3K | |
| 02-May-24 7:46 PM View: | Wettig Thane CEO Director | Fibrogen Inc (FGEN) | 01-May-24 | Payment of Exercise | 20,840 | $1.17 | $24,382.80 | (4%) 470.4K to 449.56K | |
| 25-Mar-24 5:58 PM View: | Wettig Thane CEO Director | Fibrogen Inc (FGEN) | 22-Mar-24 | Payment of Exercise | 782 | $2.58 | $2,017.56 | (< 1%) 471.18K to 470.4K | |
| 11-Mar-24 7:06 PM View: | Wettig Thane CEO | Fibrogen Inc (FGEN) | 07-Mar-24 | Private Purchase | 50,000 | $1.91 | $95,470.00 | 12% 421.18K to 471.18K | |
| 08-Mar-24 7:19 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 07-Mar-24 | Payment of Exercise | 1,181 | $1.79 | $2,113.99 | (< 1%) 204.65K to 203.47K | |
| 08-Mar-24 7:17 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 06-Mar-24 | Payment of Exercise | 23,590 | $1.87 | $44,113.30 | (6%) 364.62K to 341.03K | |
| 08-Mar-24 7:18 PM View: | Wettig Thane CEO | Fibrogen Inc (FGEN) | 06-Mar-24 | Payment of Exercise | 4,535 | $1.87 | $8,480.45 | (1%) 425.71K to 421.18K | |
| 08-Mar-24 7:17 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 06-Mar-24 | Grant | 781 | -- | -- | < 1% 363.84K to 364.62K | |
| 08-Mar-24 7:19 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 06-Mar-24 | Grant | 781 | -- | -- | < 1% 224.62K to 225.4K | |
| 08-Mar-24 7:19 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 06-Mar-24 | Payment of Exercise | 20,749 | $1.87 | $38,800.60 | (9%) 225.4K to 204.65K | |
| 08-Mar-24 7:18 PM View: | Wettig Thane CEO | Fibrogen Inc (FGEN) | 06-Mar-24 | Grant | 781 | -- | -- | < 1% 424.93K to 425.71K | |
| 23-Feb-24 8:29 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 21-Feb-24 | Grant | 29,000 | -- | -- | 9% 334.84K to 363.84K | |
| 23-Feb-24 8:28 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 21-Feb-24 | Grant | 52,000 | -- | -- | 30% 172.62K to 224.62K | |
| 23-Feb-24 8:33 PM View: | Wettig Thane CEO | Fibrogen Inc (FGEN) | 21-Feb-24 | Grant | 166,000 | -- | -- | 64% 258.93K to 424.93K | |
| 05-Feb-24 8:08 PM View: | Wettig Thane CEO | Fibrogen Inc (FGEN) | 01-Feb-24 | Payment of Exercise | 23,490 | $2.37 | $55,671.30 | (8%) 282.42K to 258.93K | |
| 26-Dec-23 7:28 PM View: | Wettig Thane CEO | Fibrogen Inc (FGEN) | 22-Dec-23 | Payment of Exercise | 819 | $0.76 | $622.44 | (< 1%) 283.24K to 282.42K | |
| 11-Dec-23 4:21 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 07-Dec-23 | Payment of Exercise | 1,085 | $0.62 | $667.71 | (< 1%) 173.7K to 172.62K | |
| 11-Dec-23 4:19 PM View: | Wettig Thane CEO | Fibrogen Inc (FGEN) | 06-Dec-23 | Payment of Exercise | 1,680 | $0.58 | $974.40 | (< 1%) 284.92K to 283.24K | |
| 11-Dec-23 4:20 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 06-Dec-23 | Payment of Exercise | 18,182 | $0.58 | $10,545.60 | (5%) 353.02K to 334.84K | |
| 11-Dec-23 4:21 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 06-Dec-23 | Payment of Exercise | 15,573 | $0.58 | $9,032.34 | (8%) 189.28K to 173.7K | |
| 03-Nov-23 4:20 PM View: | Wettig Thane CEO | Fibrogen Inc (FGEN) | 01-Nov-23 | Payment of Exercise | 21,841 | $0.55 | $11,949.20 | (7%) 306.76K to 284.92K | |
| 25-Sep-23 7:37 PM View: | Wettig Thane Interim CEO | Fibrogen Inc (FGEN) | 22-Sep-23 | Payment of Exercise | 819 | $0.79 | $643.98 | (< 1%) 307.58K to 306.76K | |
| 08-Sep-23 5:03 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 07-Sep-23 | Payment of Exercise | 1,096 | $0.99 | $1,088.11 | (< 1%) 190.37K to 189.28K | |
| 08-Sep-23 4:58 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 06-Sep-23 | Payment of Exercise | 3,308 | $0.96 | $3,185.93 | (< 1%) 356.33K to 353.02K | |
| 08-Sep-23 5:03 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 06-Sep-23 | Payment of Exercise | 711 | $0.96 | $684.76 | (< 1%) 191.08K to 190.37K | |
| 08-Sep-23 4:59 PM View: | Eisner Mark EVP, Chief Medical Officer | Fibrogen Inc (FGEN) | 06-Sep-23 | Payment of Exercise | 1,860 | $0.96 | $1,791.37 | (1%) 161.78K to 159.92K | |
| 08-Sep-23 5:00 PM View: | Wettig Thane Interim CEO | Fibrogen Inc (FGEN) | 06-Sep-23 | Payment of Exercise | 1,680 | $0.96 | $1,618.01 | (< 1%) 309.26K to 307.58K | |
| 06-Sep-23 8:54 PM View: | Henderson Jeffrey William Director | Fibrogen Inc (FGEN) | 01-Sep-23 | Sale (Planned) | 2,000 | $1.03 | $2,060.00 | (6%) 30.87K to 28.87K | |
| 06-Sep-23 8:55 PM View: | Eisner Mark EVP, Chief Medical Officer | Fibrogen Inc (FGEN) | 01-Sep-23 | Payment of Exercise | 1,085 | $1.06 | $1,150.10 | (< 1%) 162.86K to 161.78K | |
| 01-Sep-23 7:37 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 30-Aug-23 | Grant | 120,000 | -- | -- | 51% 236.33K to 356.33K | |
| 01-Sep-23 7:38 PM View: | Graham Juan Chief Financial Officer | Fibrogen Inc (FGEN) | 30-Aug-23 | Grant | 120,000 | -- | -- | 169% 71.08K to 191.08K | |
| 09-Aug-23 5:28 PM View: | Wettig Thane Chief Commercial Officer | Fibrogen Inc (FGEN) | 07-Aug-23 | Grant | 200,000 | -- | -- | 185% 108.26K to 308.26K | |
| 08-Aug-23 7:10 PM View: | Henderson Jeffrey William Director | Fibrogen Inc (FGEN) | 04-Aug-23 | Sale (Planned) | 2,000 | $1.91 | $3,820.00 | (6%) 32.87K to 30.87K | |
| 13-Jul-23 8:28 PM View: | Henderson Jeffrey William Director | Fibrogen Inc (FGEN) | 11-Jul-23 | Sale (Planned) | 2,000 | $2.69 | $5,380.00 | (6%) 34.87K to 32.87K | |
| 10-Jul-23 7:36 PM View: | Conterno Enrique A Chief Executive Officer Director | Fibrogen Inc (FGEN) | 07-Jul-23 | Sale | 1,880 | $2.80 | $5,264.00 | (< 1%) 404.4K to 402.52K | |
| 26-Jun-23 4:27 PM View: | Wettig Thane Chief Commercial Officer | Fibrogen Inc (FGEN) | 23-Jun-23 | Private Sale | 791 | $16.53 | $13,075.00 | (< 1%) 109.05K to 108.26K | |
| 15-Jun-23 8:17 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 14-Jun-23 | Sale (Planned) | 6,250 | $16.79 | $104,925.00 | (3%) 242.58K to 236.33K | |
| 15-Jun-23 8:17 PM View: | Chung Christine SVP, China Operations | Fibrogen Inc (FGEN) | 13-Jun-23 | Private Sale (Planned) | 6,250 | $17.60 | $110,000.00 | (3%) 248.83K to 242.58K | |
| 09-Jun-23 7:53 PM View: | Edwards Jeffrey L Director | Fibrogen Inc (FGEN) | 09-Jun-23 | Sale (Planned) | 7,889 | $17.19 | $135,622.00 | (19%) 41.87K to 33.98K | |
| 09-Jun-23 7:56 PM View: | Cravatt Benjamin Director | Fibrogen Inc (FGEN) | 09-Jun-23 | Sale (Planned) | 3,944 | $17.17 | $67,717.30 | (12%) 32.68K to 28.74K |
